Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ImpediMed.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo gives his NINE picks to fill the Christmas stocking with some ASX health stocks
Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat as a pancake but hopes still of Christmas rally
News
Market Highlights: Wall Street sentiment remains high, 9 most innovative firms, and 5 small caps to watch today
Health & Biotech
ScoPo’s Powerplays: Who fancies 22 minutes of exercise? And ASX health stocks are up (finally)
Health & Biotech
ASX Health Stocks: BOD says all trials are done, and it’s time to begin commercialising Aqua Phase
Health & Biotech
2023 ASX biotech darling Neuren among sector stocks with upcoming catalysts
Health & Biotech
ScoPo’s Powerplays: Mesoblast sinks Health sector, and how to live 24 years longer
News
In Case You Missed It: Gold, biotech and some gas
Health & Biotech
ASX Health Stocks: Recce Pharma and Impedimed surge 15pc after positive announcements
Health & Biotech
These were the best ASX biotechs as Health Care sprang back to life in FY23
Health & Biotech
Which ASX health companies are making strides in world’s largest healthcare market?
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test
Health & Biotech
ScoPo’s Powerplays: ASX health stocks… could be worse
Health & Biotech
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good news
News
Closing Bell: It’s a win for the ASX, loss for the newly unemployed as Aussie jobless rate rises
Health & Biotech
